European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live04-06 23:06

European equities traded in the US as American depositary receipts started the week lower late Monday morning, declining 0.21% to 1,753.66 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Cellectis (CLLS), which rose 5% and 2.6% respectively. They were followed by telecommunications company Nokia (NOK) and 3D printer company Materialise (MTLS), which were up 1.5% and 1.1% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and software firm SAP (SAP), which fell 1.7% and 1% respectively. They were followed by telecommunications company Ericsson (ERIC) and semiconductor company Sequans Communications (SQNS), which were off 0.4% and 0.2% respectively.

The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and software company Endava (DAVA), which advanced 3.7% and 1.2% respectively. They were followed by communications company WPP (WPP) and lender Lloyds Banking Group (LYG), which increased 1.2% and 0.5% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which tumbled 22% and 21.2% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and mining company BHP Group (BHP), which were down 3.2% and 1.1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment